Keywords
Hemodialysis Solutions
Renal Dialysis
Kidney Diseases
Interventional Radiology
Nephrology
How to Cite
Abstract
Background: End-stage renal disease is a major public health problem. Achieving and maintaining long-term vascular access becomes difficult and challenging in those patients on hemodialysis for renal replacement therapy. The HeRO® graft device (Merit Medical), has emerged as a possible solution for patients with limited options for hemodialysis.
Purpose: In this article, a review of the generalities, indications, cost-effectiveness, disadvantages and potential complications of said device is carried out through a search of the literature available to date.
Methodology: A systematic literature search of published studies without language limitation was performed in order to obtain greater sensitivity and yield higher search results, using the electronic databases of MEDLINE, LILACS and Europe PMC until August 25, 2022. The words used for the search were "Renal Insufficiency, Chronic ", "Dialysis", "Renal Dialysis ", "Hero Graft access Device" and "Hero graft".
Results: The use of the HeRO® device has a promising future as it offers a novel way to avoid the deadly risks of prolonged catheter dependence. Careful patient selection, experience and creativity in endovascular surgery and interventionism, as well as experienced management by dialysis providers, will be required to promote and maintain quality outcomes.
Conclusions: The long-term quality outcomes of the HeRO® graft will ultimately define its place in the vascular access arena. The device offers a novel way to avoid the deadly risks of prolonged catheter dependence.
References
United States Renal Data System. USRDS 2010 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Maryland, Estados Unidos: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013.
Kensinger C, Brownie E, Jr Bream P, Moore D. Multidisciplinary team approach to end-stage dialysis access patients. J Surg Res. 2015 nov.;199(1):259-65. https://doi.org/10.1016/j.jss.2015.04.088
James MT, Manns BJ, Hemmelgarn BR, Ravani P. Controversies and Concerns in Hemodialysis Series Editor: Marcello Tonelli: What’s Next After Fistula First: Is an Arteriovenous Graft or Central Venous Catheter Preferable When an Arteriovenous Fistula Is Not Possible?. Semin Dial. 2009;22:539. https://doi.org/10.1111/j.1525-139X.2009.00633.x
Hakim RM, Himmelfarb J. Hemodialysis access failure: a call-to-action e revisted. Kidney Int. 2009;76:1040. https://doi.org/10.1038/ki.2009.318
Dageforde LA, Bream PR, Moore DE. Hemodialysis reliable outflow (HeRO) device in end-stage dialysis access: a decision analysis model. J Surg Res. 2012;177:165. https://doi.org/10.1016/j.jss.2012.04.041
Proksch DM, Rodriguez LE, Rathore A, Steerman SN, Panneton JM. A comparison of stenting versus hemodialysis reliable outflow graft for hemodialysis patients with recurrent central venous obstructions. J Vasc Surg Venous Lymphat Disord. 2021 sept.;9(5):1136-44. https://doi.org/10.1016/j.jvsv.2021.01.001
Al Shakarchi J, Houston JG, Jones RG, Inston N. A Review on the Hemodialysis Reliable Outflow (HeRO) Graft for Haemodialysis Vascular Access. Eur J Vasc Endovasc Surg. 2015 jul.;50(1):108-13. https://doi.org/10.1016/j.ejvs.2015.03.059
Wallace JR, Chaer RA, Dillavou ED. Report on the Hemodialysis Reliable Outflow (HeRO) experience in dialysis patients with central venous occlusions. J Vasc Surg. 2013 sept.;58(3):742-7. https://doi.org/10.1016/j.jvs.2013.02.018
Bigotte Vieira M, Ferreira T, Fortes A, Martins P, Ministro A, Ferreira H, et al. Hemodialysis Reliable Outflow (HeRO) Graft device: a lifesaving solution in multiple vascular access failure in haemodialysis patients. Portuguese J Nephrol Hypertens. 2016;30;217-22.
Al Shakarchi J, Inston N, Jones RG, Maclaine G, Hollinworth D. Cost analysis of the Hemodialysis Reliable Outflow (HeRO) Graft compared to the tunneled dialysis catheter. J Vasc Surg. 2016 abr.;63(4):1026-33. https://doi.org/10.1016/j.jvs.2015.10.089
Davis KL, Gurley JC, Davenport DL, Xenos ES. The use of HeRo catheter in catheter-dependent dialysis patients with superior vena cava occlusion. J Vasc Access. 2016 mzo.;17(2):138-42. https://doi.org/10.5301/jva.5000493
Illig KA, London MJ, Aruny J, Ross JR. Safe and effective HeRO graft placement: Technique and results. J Vasc Access. 2021 abr.;19:11297298211008085. https://doi.org/10.1177/11297298211008085
Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin A, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis. 2020;75(4 supl. 2):S1-164. https://doi.org/10.1053/j.ajkd.2019.12.001
Torrent DJ, Maness MR, Kachare SD, Zink J, Haisch C, Harland R, et al. Examining hemodialysis reliable outflow catheter performance and cost in hemodialysis access. J Surg Res 2014; 192:1. https://doi.org/10.1016/j.jss.2014.03.016
Kokkosis AA, Abramowitz SD, Schwitzer J, Schanzer H, Teodorescu, V. Experience of HeRO dialysis graft placement in a challenging population. Vasc Endovascular Surg 2013;47:278. https://doi.org/10.1177/1538574413481117
Maqsood M, Rubab K. Quality of Life of Patients Using the Hemodialysis Reliable Outflow (HeRO) Graft in Hemodialysis. Cureus. 2019;11(1):e3915. https://doi.org/10.7759/cureus.3915
Nassar GM, Glickman MH, McLafferty RB, Croston JK, Zarge JI, Katzman HE, et al. A comparison between the HeRO graft and conventional arterio-venous grafts in hemodialysis patients. Semin Dial. 2014;27(3):310-8. https://doi.org/10.1111/sdi.12173
Merit Medical. Hemodialysis reliable outflow graft. https://www.merit.com/peripheral-intervention/access/renal-therapies-accessories/merit-hero-graft/
Gage SM, Katzman HE, Ross JR, Hohmann SE, Sharpe CA, Butterly DW, et al. Multicenter experience of 164 consecutive hemodialysis reliable outflow [HeRO] graft implants for hemodialysis treatment. Eur J Vasc Endovasc Surg. 2012;44:93. https://doi.org/10.1016/j.ejvs.2012.04.011
Steerman SN, Wagner J, Higgins JA, Kim C, Mirza A, Pavela J, et al. Outcomes comparison of HeRO and lower extremity arteriovenous grafts in patients with long-standing renal failure. J Vasc Surg. 2013 mzo.;57(3):776-83. https://doi.org/10.1016/j.jvs.2012.09.040
Ratcliff DC, Hansrani MM. From ZeRO to HeRO: Saving lives one HeRO at a time. Int J Surg Case Rep. 2016;27:90-2. https://doi.org/10.1016/j.ijsu.2016.08.134
Katzman HE, McLafferty RB, Ross JR, Glickman MH, Peden E, Lawson J. Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients. J Vasc Surg. 2009 sept.;50(3):600-7. https://doi.org/10.1016/j.jvs.2009.04.014
Nassar GM. Long-term performance of the hemodialysis reliable outflow (HeRO) device: the 56-month follow-up of the first clinical trial patient. Semin Dial. 2010;23:229. https://doi.org/10.1111/j.1525-139X.2010.00713.x
Kudlaty EA, Pan J, Allemang MT, Kendrick DE, Kashyap V, Wong V. The end stage of dialysis access: femoral graft or HeRO vascular access device. Ann Vasc Surg. 2015 en.;29(1):90-7. https://doi.org/10.1016/j.avsg.2014.06.001
Cline BC, Gage SM, Ronald J, Pabon-Ramos WM. Treatment of Arm Swelling in Hemodialysis Patients with Ipsilateral Arteriovenous Access and Central Vein Stenosis: Conversion to the Hemodialysis Reliable Outflow Graft versus Stent Deployment. J Vasc Interv Radiol. 2020 febr.;31(2):243-50. https://doi.org/10.1016/j.jvir.2019.06.010
Griffin AS, Gage SM, Lawson JH, Kim CY. Early infection risk with primary versus staged Hemodialysis Reliable Outflow (HeRO) graft implantation. J Vasc Surg. 2017 en.;65(1):136-41. https://doi.org/10.1016/j.jvs.2016.07.114
Leon C, Asif A. Arteriovenous access and hand pain: the distal hypoperfusion ischemic syndrome. Clin J Am Soc Nephrol. 2007 en.;2(1):175-83. https://doi.org/10.2215/CJN.02230606
Glickman MH. HeRO graft versus lower extremity grafts in hemodialysis patients with long standing renal failure. J Vasc Access. 2016 mzo.;17(supl. 1):S30-1. https://doi.org/10.5301/jva.5000531
Wasse H, Kutner N, Zhang R, Huang Y. Association of initial hemodialysis vascular access with patient-reported health status and quality of life. Clin J Am Soc Nephrol. 2007 jul.;2(4):708-14. https://doi.org/10.2215/CJN.00170107
Dengu F, Hunter J, Vrakas G, Gilbert J. The novel use of the Haemodialysis reliable outflow graft (HeRo®) in intestinal failure patients with end-stage vascular access. J Vasc Access. 2021 nov.;22(6):1021-5. https://doi.org/10.1177/1129729820961972
Yoon WJ, Lorelli DR. Two-stage Hemodialysis Reliable Outflow (HeRO) graft implantation technique that avoids the use of a femoral bridging dialysis catheter. J Vasc Access. 2015 en.;16(1):64-7. https://doi.org/10.5301/jva.5000298
Hart D, Gooden C, Cummings LS, Wible BC, Borsa J, Randall H. Modification of the HeRO graft allowing earlier cannulation and reduction in catheter dependent days in patients with end stage renal disease: a single center retrospective review. Sci World J. 2014 en. 6; 2014:318629. https://doi.org/10.1155/2014/318629
Dinwiddie LC, Patel DV. The HeRO Graft: An Innovative Vascular Access for Patients with Compromised Venous Outflow. Dialysis. 2012;207-12. https://doi.org/10.1142/9789814289764_0024
Gebhard TA, Bryant JA, Adam Grezaffi J, Pabon-Ramos WM, Gage SM, Miller MJ, et al. Percutaneous interventions on the hemodialysis reliable outflow vascular access device. J Vasc Interv Radiol. 2013 abr.;24(4):543-9. https://doi.org/10.1016/j.jvir.2012.12.027
Ladenheim ED, Lulic D, Lum C, Agrawal S. Primary and secondary patencies of transposed femoral vein fistulas are significantly greater than with the HeRO graft. J Vasc Access. 2017 my. 15;18(3):232-7. https://doi.org/10.5301/jva.5000697
Brownie ER, Kensinger CD, Feurer ID, Moore DE, Shaffer D. A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access. J Vasc Surg. 2016 nov.;64(5):1392-9. https://doi.org/10.1016/j.jvs.2016.04.055
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.